Your Location：
Home >
Browse articles >
Clinical Evidence of Oral Chinese Patent Medicines in Treatment of Chronic Kidney Disease： A Scoping Review
Clinical Evidence of Oral Chinese Patent Medicines in Treatment of Chronic Kidney Disease： A Scoping Review
Enhanced Publication- Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 20, Pages: 99-108(2023)
DOI： 10.13422/j.cnki.syfjx.20231692
Scan QR Code
Full Text(HTML)
Figs( 3 ) Tabs( 5 )
References
Publication Info
Metrics
778
Views
872
Downloads
3
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Oral Chinese Patent Medicines for Hyperlipidemia： A Scoping Review of Clinical Evidence
A Multi-dimensional Indicator-based Approach for Quality Evaluation of Chinese Patent Medicines
Mechanisms of Dahuang Gancaotang in Improving Ferroptosis in Chronic Kidney Disease through SIRT3-mediated Deacetylation of p53
A Multicenter， Double-blind，Randomized Controlled Study of Qingfei Huatan Tongqiao Formula for Treating Adenoid Hypertrophy in Children
Effect of Shaoyao Gancaotang on Proliferation and Differentiation of Neural Stem Cells in Rats with Limb Spasticity of Cerebral Apoplexy
Related Author
PANG Qing
YANG Ya-nan
WU Qian
NI Qing
LIAO Xing
LI Shuangyan
LI Siyuan
CHEN Sha
Related Institution
Guang'anmen Hospital， China Academy of Chinese Medical Sciences
Institute of Basic Research in Clinical Medicine，China Academy of Chinese Medical Sciences
State Key Laboratory for Quality Assurance and Sustainable Use of Dao-di Herbs， Institute of Chinese Materia Medica， China Academy of Chinese Medical Sciences
Tianjin University of Traditional Chinese Medicine
Geriatric Hospital of Wuhan University of Science and Technology
Chat
